Showing results (1291-1300 of 1,350) with videos related to
Sort By:
Pageof 135
Seminars in Arthritis and Rheumatism|April 17, 2025
Real-world comparative effectiveness study of Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs in Korean patients with rheumatoid arthritisSoo-Kyung Cho, Se Rim Choi, Hye Won Kim, et al.Journal of Korean Medical Science|February 3, 2011
Etiology of invasive bacterial infections in immunocompetent children in Korea (1996-2005): a retrospective multicenter studyJoon-Ho Lee, Hye Kyung Cho, Kyung-Hyo Kim, et al.Journal of Neurogastroenterology and Motility|July 2, 2020
The Practice of Gastrointestinal Motility Laboratory During COVID-19 Pandemic: Position Statements of the Asian Neurogastroenterology and Motility Association (ANMA-GML-COVID-19 Position Statements)Kewin T H Siah, M Masudur Rahman, Andrew M L Ong, et al.Neurogastroenterology and Motility|November 26, 2024
Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi-Center, Randomized, Double-Blind, Active-Comparator Phase 4 TrialCheol Min Shin, Suck Chei Choi, Jin Woong Cho, et al.Scientific Reports|August 30, 2024
Longitudinal dynamics of circulating tumor DNA for treatment monitoring in patients with breast cancer recurrenceTae-Kyung Robyn Yoo, Ji-Young Lee, Hwan Park, et al.The Lancet. Oncology|October 8, 2019
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 studyMyung-Ju Ahn, Ji-Youn Han, Ki Hyeong Lee, et al.Cancer Research and Treatment|September 5, 2018
A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13Kwai Han Yoo, Su Jin Lee, Jinhyun Cho, et al.The Korean Journal of Internal Medicine|June 19, 2023
Comparative effectiveness of JAK inhibitors and biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritisSoo-Kyung Cho, Hyoungyoung Kim, Yeo-Jin Song, et al.Scientific Reports|June 9, 2016
Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritisKwangwoo Kim, So-Young Bang, Katsunori Ikari, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2025
Proliferation of tumor-related regulatory T cells in circulation dictates efficacy of chemoimmunotherapy in triple-negative breast cancerSeung Hyuck Jeon, Koung Jin Suh, Sungmin Jung, et al.Pageof 135